Total Positions
89
Quarter
2025 Q4
Top Holding
VSTM (15.4%)
Top 10 Concentration
53.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 89
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VSTM
VERASTEM INC
|
Healthcare | 15.40% | 19.17% |
#1
Prev: #1
|
8.2 | 62,047 | 2.3% |
P
S
|
2,732,079 | $21,091,650 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 9.85% | 8.81% |
#2
Prev: #2
|
5.9 | 1,000 | 0.1% |
P
S
|
740,000 | $13,497,600 | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EOLS
EVOLUS INC
|
Healthcare | 7.92% | 7.67% |
#3
Prev: #3
|
5.2 | 95,197 | 6.2% |
P
S
|
1,631,588 | $10,850,060 | 2018 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZVRA
ZEVRA THERAPEUT...
|
Healthcare | 3.72% | 6.26% |
#4
Prev: #4
|
1.6 | -240,912 | -29.7% |
P
S
|
569,088 | $5,099,028 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 3.51% | 0.97% |
#5
18
Prev: #23
|
3.7 | 1,613,128 | 219.5% |
P
S
|
2,348,147 | $4,813,701 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABEO
ABEONA THERAPEU...
|
Healthcare | 2.73% | 1.94% |
#6
9
Prev: #15
|
3.3 | 258,535 | 57.3% |
P
S
|
709,505 | $3,739,091 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 2.62% | 3.93% |
#7
2
Prev: #5
|
1.0 | no change | no change |
P
S
|
85,000 | $3,593,800 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INDV
INDIVIOR PLC
|
Healthcare | 2.62% | 1.96% |
#8
6
Prev: #14
|
1.0 | no change | no change |
P
S
|
100,000 | $3,588,000 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 2.32% | — |
#9
Prev: #—
|
2.9 | 389,916 | no change |
NEW
|
389,916 | $3,173,916 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KZIA
KAZIA THERAPEUT...
|
Healthcare | 2.32% | — |
#10
Prev: #—
|
2.9 | 460,359 | no change |
NEW
|
460,359 | $3,171,874 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XOMA
XOMA ROYALTY CO...
|
Healthcare | 2.23% | 3.62% |
#11
4
Prev: #7
|
0.9 | -459 | -0.4% |
P
S
|
115,000 | $3,057,850 | 2017 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRCA
VERRICA PHARMAC...
|
Healthcare | 2.15% | — |
#12
Prev: #—
|
2.9 | 353,669 | no change |
NEW
|
353,669 | $2,938,989 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYBN
CYBIN INC
|
Healthcare | 2.03% | — |
#13
Prev: #—
|
2.8 | 339,902 | no change |
NEW
|
339,902 | $2,780,398 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TELA
TELA BIO INC
|
Healthcare | 2.03% | 2.61% |
#14
1
Prev: #13
|
2.8 | 196,513 | 9.1% |
P
S
|
2,352,032 | $2,775,398 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.95% | 3.03% |
#15
7
Prev: #8
|
0.9 | -74,544 | -42.7% |
P
S
|
100,000 | $2,671,000 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRSP
CALL
CRISPR THERAPEU...
|
CALL Option | 1.91% | — |
#16
Prev: #—
|
2.8 | 50,000 | no change |
NEW
|
50,000 | $2,622,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZN
SURROZEN INC
|
Healthcare | 1.87% | 2.62% |
#17
5
Prev: #12
|
0.9 | -136,515 | -54.6% |
P
S
|
113,631 | $2,568,061 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARE
CALL
ALEXANDRIA REAL...
|
CALL Option | 1.79% | — |
#18
Prev: #—
|
2.7 | 50,000 | no change |
NEW
|
50,000 | $2,447,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 1.73% | 2.94% |
#19
9
Prev: #10
|
0.8 | -462,765 | -43.8% |
P
S
|
593,573 | $2,374,292 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
CALL
ULTRAGENYX PHAR...
|
CALL Option | 1.68% | — |
#20
Prev: #—
|
2.7 | 100,000 | no change |
NEW
|
100,000 | $2,300,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AYTU
AYTU BIOPHARMA ...
|
Healthcare | 1.54% | 1.36% |
#21
2
Prev: #19
|
0.6 | -78,151 | -8.8% |
P
S
|
813,704 | $2,115,630 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
CALL
NEKTAR THERAPEU...
|
CALL Option | 1.54% | — |
#22
Prev: #—
|
2.6 | 50,000 | no change |
NEW
|
50,000 | $2,114,000 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DAWN
DAY ONE BIOPHAR...
|
Healthcare | 1.36% | 3.71% |
#23
17
Prev: #6
|
0.8 | -447,382 | -69.1% |
P
S
|
200,000 | $1,864,000 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACET
ADICET BIO INC
|
Healthcare | 1.35% | — |
#24
Prev: #—
|
2.5 | 220,011 | no change |
NEW
|
220,011 | $1,852,493 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 1.26% | — |
#25
Prev: #—
|
2.5 | 19,742 | no change |
NEW
|
19,742 | $1,719,726 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 1.32% |
Sold All 😨
(Was: #20) |
0.3 | -24,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALMS
ALUMIS INC
|
Healthcare | 0.00% | 0.97% |
Sold All 😨
(Was: #22) |
0.3 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.00% | 0.90% |
Sold All 😨
(Was: #25) |
0.3 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DVAX
DYNAVAX TECHNOL...
|
Healthcare | 0.00% | 0.87% |
Sold All 😨
(Was: #27) |
0.3 | -108,094 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VNDA
VANDA PHARMACEU...
|
Healthcare | 0.00% | 0.79% |
Sold All 😨
(Was: #29) |
0.3 | -195,000 | -100.0% |
CLOSED
|
— | $— | 2015 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 0.00% | 0.74% |
Sold All 😨
(Was: #30) |
0.3 | -160,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANGO
ANGIODYNAMICS I...
|
Healthcare | 0.00% | 0.54% |
Sold All 😨
(Was: #35) |
0.3 | -60,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GRCE
GRACE THERAPEUT...
|
Healthcare | 0.00% | 0.51% |
Sold All 😨
(Was: #36) |
0.3 | -211,010 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 0.49% |
Sold All 😨
(Was: #37) |
0.3 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.00% | 0.47% |
Sold All 😨
(Was: #38) |
0.3 | -37,200 | -100.0% |
CLOSED
|
— | $— | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #39) |
0.3 | -100,600 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HCAT
HEALTH CATALYST...
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #42) |
0.3 | -155,551 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.00% | 0.35% |
Sold All 😨
(Was: #43) |
0.3 | -10,585 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.00% | 0.32% |
Sold All 😨
(Was: #45) |
0.3 | -125,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #47) |
0.3 | -40,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 0.00% | 0.30% |
Sold All 😨
(Was: #48) |
0.3 | -192,900 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HSDT
HELIUS MED TECH...
|
Financial Services | 0.00% | 0.24% |
Sold All 😨
(Was: #50) |
0.3 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SVRA
SAVARA INC
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #52) |
0.3 | -60,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #53) |
0.3 | -2,500 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #55) |
0.3 | -25,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMMB
CHEMOMAB THERAP...
|
Healthcare | 0.00% | 0.06% |
Sold All 😨
(Was: #56) |
0.3 | -30,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #57) |
0.3 | -35,253 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JSPR
JASPER THERAPEU...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #58) |
0.3 | -20,200 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 89 holdings